<DOC>
	<DOC>NCT01835860</DOC>
	<brief_summary>To evaluate whether Prostatic Artery Embolization (PAE) might be an effective alternative treatment option for benign prostatic hyperplasia (BPH), in comparison to current gold standard surgical treatment- Transurethral Resection of Prostate (TURP).</brief_summary>
	<brief_title>Prostatic Artery Embolization for Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>1. Moderate to severe lower urinary tract symptoms (i.e. International prostate symptom score IPSS&gt;8) who are bothered by their symptoms (i.e., interfere with the daily activities of living) 2. Urinary retention (related to BPH) leading to catheterization. 3. Refractory to medical treatment or patient is not willing to consider medical treatment 4. Pre transurethral resection of prostate (TURP) to reduce the size of prostate gland if prostate is too big for TURP surgery. 1. Mild symptoms (IPSS &lt;8) 2. Moderate to severe lower urinary tract symptoms (i.e. IPSS&gt;8) who are not bothered by their symptoms (i.e., symptoms do not interfere with the daily activities of living). 3. Suspected malignancy. 4. Any of the following clearly related to BPH bladder stones, recurrent UTIs, and renal insufficiency. 5. Advanced atherosclerosis and unsuitable vascular access. 6. Allergy to intravenous contra</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>BPH</keyword>
</DOC>